These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 9794370)

  • 1. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.
    Hjelmström P; Juedes AE; Fjell J; Ruddle NH
    J Immunol; 1998 Nov; 161(9):4480-3. PubMed ID: 9794370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.
    Lyons JA; Ramsbottom MJ; Cross AH
    Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice.
    Amor S; Groome N; Linington C; Morris MM; Dornmair K; Gardinier MV; Matthieu JM; Baker D
    J Immunol; 1994 Nov; 153(10):4349-56. PubMed ID: 7525700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination.
    Svensson L; Abdul-Majid KB; Bauer J; Lassmann H; Harris RA; Holmdahl R
    Eur J Immunol; 2002 Jul; 32(7):1939-46. PubMed ID: 12115614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
    Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice.
    Mendel Kerlero de Rosbo N; Ben-Nun A
    Eur J Immunol; 1996 Oct; 26(10):2470-9. PubMed ID: 8898962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
    Mendel I; Kerlero de Rosbo N; Ben-Nun A
    Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells.
    Samoilova EB; Horton JL; Hilliard B; Liu TS; Chen Y
    J Immunol; 1998 Dec; 161(12):6480-6. PubMed ID: 9862671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
    Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
    J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55.
    Ichikawa M; Johns TG; Liu J; Bernard CC
    J Immunol; 1996 Jul; 157(2):919-26. PubMed ID: 8752946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the bm12 class II mutation on proliferative and cytokine responses of encephalitogenic T cells in myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis.
    Gur H; Mendel I; Kerlero de Rosbo N; Ben-Nun A
    J Autoimmun; 1999 Aug; 13(1):3-10. PubMed ID: 10441162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation.
    Tsunoda I; Kuang LQ; Igenge IZ; Fujinami RS
    J Neuroimmunol; 2005 Mar; 160(1-2):122-34. PubMed ID: 15710465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
    Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
    J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response.
    Stefferl A; Brehm U; Storch M; Lambracht-Washington D; Bourquin C; Wonigeit K; Lassmann H; Linington C
    J Immunol; 1999 Jul; 163(1):40-9. PubMed ID: 10384097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to myelin oligodendrocyte glycoprotein are not involved in the severity of chronic non-remitting experimental autoimmune encephalomyelitis.
    Sekiguchi Y; Ichikawa M; Takamoto M; Ota H; Koh CS; Muramatsu M; Honjo T; Agematsu K
    Immunol Lett; 2009 Feb; 122(2):145-9. PubMed ID: 18824198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.
    Chan J; Ban EJ; Chun KH; Wang S; McQualter J; Bernard C; Toh BH; Alderuccio F
    Autoimmunity; 2008 Aug; 41(5):405-13. PubMed ID: 18568646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
    Samoilova EB; Horton JL; Chen Y
    Cell Immunol; 1998 Sep; 188(2):118-24. PubMed ID: 9756642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice.
    Smith PA; Heijmans N; Ouwerling B; Breij EC; Evans N; van Noort JM; Plomp AC; Delarasse C; 't Hart B; Pham-Dinh D; Amor S
    Eur J Immunol; 2005 Apr; 35(4):1311-9. PubMed ID: 15761848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice.
    Delarasse C; Daubas P; Mars LT; Vizler C; Litzenburger T; Iglesias A; Bauer J; Della Gaspera B; Schubart A; Decker L; Dimitri D; Roussel G; Dierich A; Amor S; Dautigny A; Liblau R; Pham-Dinh D
    J Clin Invest; 2003 Aug; 112(4):544-53. PubMed ID: 12925695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.